We are live on ! Find out more
PCRX icon

Pacira BioSciences
PCRX

239 hedge funds and large institutions have $1.24B invested in Pacira BioSciences in 2025 Q3 according to their latest regulatory filings, with 37 funds opening new positions, 67 increasing their positions, 95 reducing their positions, and 30 closing their positions.

New
Increased
Maintained
Reduced
Closed

374% more call options, than puts

Call options by funds: $3.13M | Put options by funds: $661K

100% more funds holding in top 10

Funds holding in top 10: 1 → 2 (+1)

23% more first-time investments, than exits

New positions opened: 37 | Existing positions closed: 30

3% more funds holding

Funds holding: 233 → 239 (+6)

2% more capital invested

Capital invested by funds: $1.21B → $1.24B (+$28.4M)

2.41% less ownership

Funds ownership: 109.17% → 106.76% (-2.4%)

29% less repeat investments, than reductions

Existing positions increased: 67 | Existing positions reduced: 95

Holders
239
Holders Change
+6
Holders Change %
+2.58%
% of All Funds
3.14%
Holding in Top 10
2
Holding in Top 10 Change
+1
Holding in Top 10 Change %
+100%
% of All Funds
0.03%
New
37
Increased
67
Reduced
95
Closed
30
Calls
$3.13M
Puts
$661K
Net Calls
+$2.47M
Net Calls Change
-$2.36M

Top Buyers

1
DPCM
Doma Perpetual Capital Management
Florida
+$22M
2
Adage Capital Partners
Adage Capital Partners
Massachusetts
+$10.1M
3
American Century Companies
American Century Companies
Missouri
+$4.81M
4
Morgan Stanley
Morgan Stanley
New York
+$4.73M
5
Royal Bank of Canada
Royal Bank of Canada
Ontario, Canada
+$4.16M

Top Sellers

1
PCH
Polar Capital Holdings
United Kingdom
-$21.8M
2
BlackRock
BlackRock
New York
-$11.3M
3
EC
EcoR1 Capital
California
-$10.9M
4
Millennium Management
Millennium Management
New York
-$10.9M
5
Jacobs Levy Equity Management
Jacobs Levy Equity Management
New Jersey
-$8.16M
Name Holding Trade Value Shares
Change 		Change in
Stake
II
126
Inspire Investing
Idaho
$448K +$20.8K +846 +5%
HSBC Holdings
127
HSBC Holdings
United Kingdom
$443K -$113K -4,585 -21%
Qube Research & Technologies (QRT)
128
Qube Research & Technologies (QRT)
United Kingdom
$420K +$401K +16,307 New
Zurich Cantonal Bank
129
Zurich Cantonal Bank
Switzerland
$419K -$4.79K -195 -1%
Natixis Advisors
130
Natixis Advisors
Massachusetts
$415K +$71.4K +2,905 +22%
SG Americas Securities
131
SG Americas Securities
New York
$405K +$227K +9,251 +143%
FM
132
Foster & Motley
Ohio
$388K +$370K +15,073 New
Universal-Beteiligungs- und Servicegesellschaft
133
Universal-Beteiligungs- und Servicegesellschaft
Germany
$387K -$64.5K -2,624 -15%
GCA
134
Greenwood Capital Associates
South Carolina
$384K +$42.8K +1,742 +13%
YCM
135
Yousif Capital Management
Michigan
$366K -$82.7K -3,366 -19%
ASRS
136
Arizona State Retirement System
Arizona
$353K +$5.18K +211 +2%
PAP
137
Persistent Asset Partners
Hong Kong
$350K – – –
HighTower Advisors
138
HighTower Advisors
Illinois
$339K +$323K +13,170 New
TRSOTSOK
139
Teachers Retirement System of the State of Kentucky
Kentucky
$339K -$42K -1,709 -11%
AB
140
Amalgamated Bank
New York
$338K -$2.7K -110 -0.8%
State Board of Administration of Florida Retirement System
141
State Board of Administration of Florida Retirement System
Florida
$335K – – –
EWM
142
Empirical Wealth Management
Washington
$334K +$318K +12,957 New
PFSRSONJ
143
Police & Firemen's Retirement System of New Jersey
New Jersey
$328K +$66.1K +2,691 +27%
SC
144
Sierra Capital
Florida
$322K – – –
Comerica Bank
145
Comerica Bank
Texas
$318K -$95.7K -3,898 -24%
A
146
AlphaQuest
New York
$316K -$56.3K -2,293 -16%
TFA
147
Toth Financial Advisory
Virginia
$309K +$295K +12,000 New
BHCM
148
Brevan Howard Capital Management
Jersey
$306K -$386K -15,732 -57%
WAM
149
Wolverine Asset Management
Illinois
$300K – – –
COPPSERS
150
Commonwealth of Pennsylvania Public School Employees Retirement System
Pennsylvania
$295K -$10.9K -445 -4%
4 5
6
7 8

PCRX Hedge Fund Activity: Q3 2025 in Review

239 of the 7,619 institutional investors tracked by Wall St. Rank reported a position in Pacira BioSciences (PCRX) for Q3 2025, worth a combined $1.24B — up 2.3% from $1.21B a quarter earlier.

Buyers outnumbered sellers: 37 funds opened new PCRX positions and 30 closed out — a net gain of 7 holders — while 67 added to existing stakes and 95 trimmed.

The largest buyer was Doma Perpetual Capital Management, adding an estimated $22M. The largest seller was Polar Capital Holdings, exiting entirely with an estimated $21.8M sold.

  • 239 institutional investors held Pacira BioSciences (PCRX) as of Q3 2025, up from 233 in Q2 2025.
  • Funds reported $1.24B of Pacira BioSciences stock for Q3 2025, up 2.3% quarter-over-quarter.
  • 37 funds opened new Pacira BioSciences positions in Q3 2025 and 30 closed out, a net change of +7 holders.
  • The largest Pacira BioSciences buyer in Q3 2025 was Doma Perpetual Capital Management, an estimated $22M added.
  • The largest Pacira BioSciences seller in Q3 2025 was Polar Capital Holdings, an estimated $21.8M sold.

Based on aggregated 13F filings for Q3 2025.